Risk-based guidance for choosing fecal immunochemical test or colonoscopy in colorectal cancer screening: a modeling study

基于风险的结直肠癌筛查中粪便免疫化学检测或结肠镜检查选择指南:一项建模研究

阅读:2

Abstract

In colorectal cancer (CRC) screening settings offering both colonoscopy and fecal immunochemical test (FIT), guidance on who should get colonoscopy could optimize resource use. This study aimed to identify efficient guidance strategies, maximizing quality-adjusted lifeyears (QALYs) gained for given colonoscopy demand. Using the MISCAN-Colon microsimulation model for Switzerland, we evaluated 3 strategy types: age-based, starting biennial FIT and switching to 10-yearly colonoscopy at a certain age; risk score-based, where only individuals with high CRC risk scores undergo colonoscopy; FIT-based, switching to colonoscopy after a quantitative FIT result just below the positivity cut-off and, in some strategies, also at a certain age. Reference strategies included (1) colonoscopy only and (2) equal proportions of individuals choosing FIT or colonoscopy at age 50. Age- and risk score-based strategies with switches or risk assessments at ages 54, 64, or 74 were efficient. Compared to the reference strategies, QALYs gained could increase by (1) 10.0% or (2) 6.7% without increasing colonoscopy demand. The FIT-based switching strategies were not efficient. Therefore, screening programs like those in Switzerland and the United States can improve efficiency by guiding individuals toward FIT or colonoscopy simply based on age. More complex approaches using prior FITs or risk scores would not outperform age-based approaches.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。